Cargando…
Nakaseomyces glabrata endocarditis: A therapeutic dilemma
Candida infective endocarditis is a rare but serious entity that often requires aggressive treatment. However, treatment can be challenging in patients infected with drug-resistant fungi and/or with substantial comorbidity. Moreover, recommendations in treatment guidelines for these patients are bas...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240517/ https://www.ncbi.nlm.nih.gov/pubmed/37283717 http://dx.doi.org/10.1016/j.mmcr.2023.04.002 |
_version_ | 1785053777109188608 |
---|---|
author | Jim, Kin Ki Daems, Joelle J.N. Boekholdt, S. Matthijs van Dijk, Karin |
author_facet | Jim, Kin Ki Daems, Joelle J.N. Boekholdt, S. Matthijs van Dijk, Karin |
author_sort | Jim, Kin Ki |
collection | PubMed |
description | Candida infective endocarditis is a rare but serious entity that often requires aggressive treatment. However, treatment can be challenging in patients infected with drug-resistant fungi and/or with substantial comorbidity. Moreover, recommendations in treatment guidelines for these patients are based on limited clinical data due to their rarity. Here we report a case of Nakaseomyces glabrata (Candida glabrata) prosthetic valve endocarditis in a patient with congenital heart disease. This case illustrates a therapeutic dilemma for Nakaseomyces glabrata prosthetic valve endocarditis and the need for novel antifungal drugs and further clinical studies. |
format | Online Article Text |
id | pubmed-10240517 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-102405172023-06-06 Nakaseomyces glabrata endocarditis: A therapeutic dilemma Jim, Kin Ki Daems, Joelle J.N. Boekholdt, S. Matthijs van Dijk, Karin Med Mycol Case Rep Case Report Candida infective endocarditis is a rare but serious entity that often requires aggressive treatment. However, treatment can be challenging in patients infected with drug-resistant fungi and/or with substantial comorbidity. Moreover, recommendations in treatment guidelines for these patients are based on limited clinical data due to their rarity. Here we report a case of Nakaseomyces glabrata (Candida glabrata) prosthetic valve endocarditis in a patient with congenital heart disease. This case illustrates a therapeutic dilemma for Nakaseomyces glabrata prosthetic valve endocarditis and the need for novel antifungal drugs and further clinical studies. Elsevier 2023-04-28 /pmc/articles/PMC10240517/ /pubmed/37283717 http://dx.doi.org/10.1016/j.mmcr.2023.04.002 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Jim, Kin Ki Daems, Joelle J.N. Boekholdt, S. Matthijs van Dijk, Karin Nakaseomyces glabrata endocarditis: A therapeutic dilemma |
title | Nakaseomyces glabrata endocarditis: A therapeutic dilemma |
title_full | Nakaseomyces glabrata endocarditis: A therapeutic dilemma |
title_fullStr | Nakaseomyces glabrata endocarditis: A therapeutic dilemma |
title_full_unstemmed | Nakaseomyces glabrata endocarditis: A therapeutic dilemma |
title_short | Nakaseomyces glabrata endocarditis: A therapeutic dilemma |
title_sort | nakaseomyces glabrata endocarditis: a therapeutic dilemma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240517/ https://www.ncbi.nlm.nih.gov/pubmed/37283717 http://dx.doi.org/10.1016/j.mmcr.2023.04.002 |
work_keys_str_mv | AT jimkinki nakaseomycesglabrataendocarditisatherapeuticdilemma AT daemsjoellejn nakaseomycesglabrataendocarditisatherapeuticdilemma AT boekholdtsmatthijs nakaseomycesglabrataendocarditisatherapeuticdilemma AT vandijkkarin nakaseomycesglabrataendocarditisatherapeuticdilemma |